ArticleAesthetic plastic surgery2025
Exosome-Mediated Enhancement of Fat Graft Retention: A Comparative Preclinical Study with Stromal Vascular Fraction.
Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCell-assisted lipotransfer (CAL) is a fat grafting technique that enhances graft survival by supplementing grafts with autologous stromal vascular fraction (SVF) or adipose-derived stromal cells (ASCs). However, its clinical translation has been hindered owing to inherent biological variability, potential cell viability issues, tumorigenic risk, and the complex regulatory landscape associated with cell-based therapies. To overcome these challenges, exosome has gained increasing attention as a promising non-cellular therapeutic modality capable of preserving key regenerative functions while minimizing relative concerns. This study aimed to compare the efficacy of SVF-enriched lipotransfer with fat co-transplanted with exosomes from ASCs to identify a reliable and clinically applicable non-cellular strategy for optimizing fat graft outcomes.
methodsIn vivo, minced human fat tissue mixed with phosphate-buffered saline, SVF cells, or exosomes was grafted into nude mice. Grafts were evaluated through microcomputed tomography at weeks 4 and 8 post-grafting and histological analysis at weeks 1 and 8 post-grafting.
resultsThe exosome group showed a significantly higher volume retention rate than the control group at weeks 4 and 8 post-grafting. Histological analysis revealed that exosomes exhibited more pronounced effects in reducing inflammation, preserving perilipin-positive adipocytes, and promoting angiogenesis in the grafted fats compared with those of SVF cells.
conclusionsOur findings highlight the potential of exosomes in improving fat graft retention and overall tissue regeneration, suggesting that fat co-transplanted with exosomes from ASCs could serve as a superior alternative to SVF-enriched lipotransfer. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.